Plain-English translation of NCT05752448 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new survivorship care program called POSTCare designed specifically for women who have completed initial treatment for ovarian cancer (stages 2–4). The program is delivered through telehealth (video visits) and aims to help you manage the transition after treatment ends and improve your overall quality of life, mood, and well-being. Half of the participants will receive this new program, while the other half will receive standard follow-up care, so researchers can see which approach works better.
Many women struggle emotionally and physically after ovarian cancer treatment ends, and doctors want to make sure survivors get better support during this critical transition period. This trial exists to test whether a structured, specialized survivorship program can help reduce depression and improve quality of life more effectively than usual care alone.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly placed into either the new POSTCare program or standard care. You will complete surveys about your quality of life, mood, and well-being at the start, after 12 weeks, and after 24 weeks. If you are in the POSTCare group, you will receive support through video visits as part of the new survivorship transition program. The entire study lasts 6 months, and all visits and surveys can be done from home.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States